Felix Pharmaceuticals achieves a significant milestone with Gulf GMP certification for its Salalah facility, enhancing its commitment to quality and safety. This achievement confirms the company’s ability to manufacture medicines that meet the highest regulatory standards.
The certification applies to the facility specialized in solid drug production within the Salalah Free Zone in Oman. By obtaining Gulf GMP certification, Felix Pharmaceuticals demonstrates full compliance with Gulf Cooperation Council (GCC) regulations. This ensures high-quality production in line with global best practices and supports the expansion of pharmaceutical products across regional markets.
Dr. Waseem Hamad, CEO of Felix Pharmaceutical Industries, explained that the certification strengthens the region’s pharmaceutical security system. He noted that the facility meets advanced technical and regulatory requirements, enhancing the industrial capabilities of Oman’s pharmaceutical sector. Moreover, the certification increases confidence in the company’s products among healthcare providers and patients.
The CEO highlighted that this recognition reinforces Salalah Free Zone as a hub for industrial and logistics excellence. The facility attracts investments in advanced industries, supporting Oman’s growing role in regional pharmaceutical manufacturing. By securing Gulf GMP certification, Felix Pharmaceuticals contributes to building stronger supply chains across the GCC.
In addition, the company plans to further develop production capabilities and expand into regional markets. Felix Pharmaceuticals aims to support healthcare systems in GCC countries and beyond, ensuring access to safe, effective medicines. These efforts demonstrate the company’s dedication to regional health, industrial innovation, as well as reliable pharmaceutical supply.
Industry experts note that GMP certification is crucial for competitiveness, safety, and international trade readiness. The Gulf GMP certification confirms Felix Pharmaceuticals’ compliance with strict standards and positions it as a trusted supplier in the region.
Overall, the certification underscores Oman’s strategic role in the pharmaceutical sector and highlights Felix Pharmaceuticals’ commitment to quality, safety, and regional healthcare advancement. The milestone also signals growing confidence in the Gulf’s pharmaceutical industry.
